Gene expression of Peg-interferon alfa-2b plus ribavirin in hepatitis C patients during the first 10 weeks of treatment

GSE11342

Homo sapiens

152 Downloadable Samples

Affymetrix Human Genome U133A Array (hgu133a)

Submitter Supplied Information

Description

Study of PBMC gene expression during the first 10 weeks of therapy with Pegylated-interferon-alfa2b (PegIntronTM) and ribavirin (administered by weight) in HCV patients.

PubMed ID

18986530

Publication Title

Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment.

Total Samples

152

Submitter’s Institution

Indiana University

Authors

Taylor MW, Tsukahara T, McClintick JN, Edenberg HJ, Kwo P

Source Repository

Gene Expression Omnibus (GEO)

No rows found